| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11077055 | DEXCEL PHARMA | Orally disintegrating compositions |
Apr, 2036
(12 years from now) | |
Lansoprazole is owned by Dexcel Pharma.
Lansoprazole contains Lansoprazole.
Lansoprazole has a total of 1 drug patent out of which 0 drug patents have expired.
Lansoprazole was authorised for market use on 07 June, 2016.
Lansoprazole is available in tablet, orally disintegrating, delayed release;oral dosage forms.
The generics of Lansoprazole are possible to be released after 21 April, 2036.
Drugs and Companies using LANSOPRAZOLE ingredient
Market Authorisation Date: 07 June, 2016
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
More Information on Dosage
LANSOPRAZOLE family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic